Literature DB >> 21550971

Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism.

Wei Huang1, Rishipal R Bansode, Yan Xie, Leslie Rowland, Madhu Mehta, Nicholas O Davidson, Kamal D Mehta.   

Abstract

The protein kinase C (PKC) family of Ca(2+) and/or lipid-activated serine-threonine protein kinases is implicated in the pathogenesis of obesity and insulin resistance. We recently reported that protein kinase Cβ (PKCβ), a calcium-, diacylglycerol-, and phospholipid-dependent kinase, is critical for maintaining whole body triglyceride homeostasis. We now report that PKCβ deficiency has profound effects on murine hepatic cholesterol metabolism, including hypersensitivity to diet-induced gallstone formation. The incidence of gallstones increased from 9% in control mice to 95% in PKCβ(-/-) mice. Gallstone formation in the mutant mice was accompanied by hyposecretion of bile acids with no alteration in fecal bile acid excretion, increased biliary cholesterol saturation and hydrophobicity indices, as well as hepatic p42/44(MAPK) activation, all of which enhance susceptibility to gallstone formation. Lithogenic diet-fed PKCβ(-/-) mice also displayed decreased expression of hepatic cholesterol-7α-hydroxylase (CYP7A1) and sterol 12α-hydroxylase (CYP8b1). Finally, feeding a modified lithogenic diet supplemented with milk fat, instead of cocoa butter, both increased the severity of and shortened the interval for gallstone formation in PKCβ(-/-) mice and was associated with dramatic increases in cholesterol saturation and hydrophobicity indices. Taken together, the findings reveal a hitherto unrecognized role of PKCβ in fine tuning diet-induced cholesterol and bile acid homeostasis, thus identifying PKCβ as a major physiological regulator of both triglyceride and cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550971      PMCID: PMC3123047          DOI: 10.1074/jbc.M111.250282

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.

Authors:  M Marrapodi; J Y Chiang
Journal:  J Lipid Res       Date:  2000-04       Impact factor: 5.922

2.  Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.

Authors:  L Amigo; V Quiñones; P Mardones; S Zanlungo; J F Miquel; F Nervi; A Rigotti
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

3.  Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin.

Authors:  Takashi Yamamoto; Kazuhisa Watanabe; Noriyuki Inoue; Yoshimi Nakagawa; Naomi Ishigaki; Takashi Matsuzaka; Yoshinori Takeuchi; Kazuto Kobayashi; Shigeru Yatoh; Akimitsu Takahashi; Hiroaki Suzuki; Naoya Yahagi; Takanari Gotoda; Nobuhiro Yamada; Hitoshi Shimano
Journal:  J Lipid Res       Date:  2010-02-23       Impact factor: 5.922

4.  Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.

Authors:  Wei Huang; Rishipal Bansode; Madhu Mehta; Kamal D Mehta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.

Authors:  Yan Xie; Valerie Blanc; Thomas A Kerr; Susan Kennedy; Jianyang Luo; Elizabeth P Newberry; Nicholas O Davidson
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

6.  Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.

Authors:  Kwang-Hoon Song; Tiangang Li; Erika Owsley; Stephen Strom; John Y L Chiang
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

7.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation.

Authors:  Ji Miao; Zhen Xiao; Deepthi Kanamaluru; Gyesik Min; Peter M Yau; Timothy D Veenstra; Ewa Ellis; Steve Strom; Kelly Suino-Powell; H Eric Xu; Jongsook Kim Kemper
Journal:  Genes Dev       Date:  2009-04-15       Impact factor: 11.361

8.  Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice.

Authors:  Yan Xie; Elizabeth P Newberry; Susan M Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2009-01-09       Impact factor: 5.922

Review 9.  Biliary lipids and cholesterol gallstone disease.

Authors:  David Q-H Wang; David E Cohen; Martin C Carey
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

10.  Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity.

Authors:  Romain Gineste; Audrey Sirvent; Réjane Paumelle; Stéphane Helleboid; Alexis Aquilina; Raphaël Darteil; Dean W Hum; Jean-Charles Fruchart; Bart Staels
Journal:  Mol Endocrinol       Date:  2008-08-28
View more
  7 in total

1.  Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.

Authors:  Ryan D Jones; Joyce J Repa; David W Russell; John M Dietschy; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-24       Impact factor: 4.052

Review 2.  PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol.

Authors:  Devina Mehta; Kamal D Mehta
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-19       Impact factor: 4.052

Review 3.  Mouse models of gallstone disease.

Authors:  Tony Y Wang; Piero Portincasa; Min Liu; Patrick Tso; David Q-H Wang
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

4.  Metabolic syndrome and gallstone disease.

Authors:  Li-Ying Chen; Qiao-Hua Qiao; Shan-Chun Zhang; Yu-Hao Chen; Guan-Qun Chao; Li-Zheng Fang
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

5.  Modulation of Hepatic Protein Kinase Cβ Expression in Metabolic Adaptation to a Lithogenic Diet.

Authors:  Wei Huang; Kamal D Mehta
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-06-03

6.  Dietary fat/cholesterol-sensitive PKCβ-RB signaling: Potential role in NASH/HCC axis.

Authors:  Wei Huang; Devina Mehta; Said Sif; Lindsey N Kent; Samson T Jacob; Kalpana Ghoshal; Kamal D Mehta
Journal:  Oncotarget       Date:  2017-05-15

Review 7.  Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review.

Authors:  Katarzyna Kolczynska; Angel Loza-Valdes; Izabela Hawro; Grzegorz Sumara
Journal:  Lipids Health Dis       Date:  2020-05-28       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.